Milestone Pharmaceuticals (MIST) announced that cardamyst nasal spray, its first commercial product, is now available through ...
CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional launch in mid-FebruaryExpected $25 copay cap for eligible commercially insured ...
GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
The United States Patent and Trademark Office has issued U.S. Patent No. 12,514,854 B2, an Orange Book-listable patent ...
Experts say there are a number of benefits — and plenty of challenges — to using nasal sprays for treatments and vaccines. (Photo illustration: Yahoo News; photos: Getty Images) Nasal sprays have long ...
In today’s fast-paced world, where respiratory infections and allergies seem to be omnipresent, finding a reliable product to maintain respiratory health is crucial. Enter Viraldine, a revolutionary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results